VaramirStart free · no cardSign in
ACAD as of Oct 31 · 18:10 ET
ACADNasdaqPharmaceutical Preparations

Acadia Pharmaceuticals Inc · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±10.2%
avg realized
±4.3%
Feb 26 '25±11.5%▲+1.79%×0.16
May 7 '25±9.6%▲+14.31%×1.50
Aug 6 '25±7.7%▲+2.52%×0.33
Q3 FY25±11.3%▼−3.05%×0.27
Jan 13 '26±6.6%▼−0.49%×0.07
Q1 FY26±9.4%▼−1.32%×0.14
May 6 '26±13.4%▲+5.03%×0.37
Q2 FY26±11.9%▲+6.08%×0.51
quarterimplied−15%0+15%realized×
Q2 FY26±11.9%▲+6.08%×0.51
May '26±13.4%▲+5.03%×0.37
Q1 FY26±9.4%▼−1.32%×0.14
Jan '26±6.6%▼−0.49%×0.07
Q3 FY25±11.3%▼−3.05%×0.27
Aug '25±7.7%▲+2.52%×0.33
2 older reports
May '25±9.6%▲+14.31%×1.50
Feb '25±11.5%▲+1.79%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings
350managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

7 of 8recent reports where the move came in under the options implied rangeEarnings history
5tracked funds holding ACADN-PORT · Aug 31 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

ACAD report session

Suppliers 1

STOKStoke Therapeutics×0.48
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±8.8% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.